A) The use of embryonic stem cells. B) The lack of potential applications. C) The ease of obtaining stem cells from adults. D) The uncontroversial ethical implications.
A) Funding from private corporations only. B) Ethical guidelines and regulations. C) Speed of research progress above all else. D) Ignoring public opinions and concerns.
A) To eliminate competition among research institutions. B) To hinder progress in the field. C) To avoid sharing scientific breakthroughs. D) To address regulatory disparities and ensure ethical standards.
A) Providing expertise on ethical implications and considerations. B) Opposing all forms of medical research involving stem cells. C) Advocating for unrestricted research with no ethical oversight. D) Serving as decision-makers for all stem cell research projects.
A) Creating financial barriers to stem cell research. B) Excluding patient advocates from the research process. C) Promoting unregulated stem cell experimentation. D) Developing international policy guidance on stem cell research.
A) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. B) Pluripotent cells are more versatile than totipotent cells. C) Pluripotent cells can only divide a limited number of times. D) There is no difference between the two types of stem cells.
A) Create artificial intelligence using stem cells. B) Speed up the aging process in patients. C) Repair, replace, and regenerate damaged cells or tissues. D) Replace traditional medicine for all illnesses.
A) To ignore public opinions and concerns. B) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. C) To prioritize scientific progress over societal implications. D) To only focus on economic factors. |